Caffeine intake in adults with cardiovascular diseases; A cross-sectional study

Basit Öğe Kaydı
dc.authorscopusid57199653274
dc.authorscopusid57777837300
dc.authorscopusid57779188800
dc.authorscopusid57779529500
dc.authorscopusid6505680586
dc.contributor.authorBozkır, Ç.
dc.contributor.authorTuğgüm, Sergen
dc.contributor.authorKağan, N.
dc.contributor.authorNizam, B.
dc.contributor.authorAlpsoy, Ş.
dc.date.accessioned2023-04-20T08:05:55Z
dc.date.available2023-04-20T08:05:55Z
dc.date.issued2022
dc.departmentYüksekokullar, Sağlık Yüksekokulu, Beslenme ve Diyetetik Bölümü
dc.description.abstractBackground: Caffeine in the safe dose range has been associated with a reduction in the risk of chronic diseases. There is evidence that caffeine intake has both protective and negative effects on cardiovascular diseases. Aim: This study aimed to investigate caffeine intake in cardiovascular patients. Methods: The study sample was selected from individuals who applied to the Cardiology policlinic of Tekirdağ Namık Kemal University Hospital. A questionnaire was applied using face-to-face interview method to determine their demographic information, nutritional status and anthropometric measurements. Moreover, the nutritional status of the participants was determined by the Food Frequency Questionnaire and the type of cardiovascular disease was determined by a physician. The blood parameters of the sample for the last three months were questioned. The sample has been ninety people of whom fifty cardiovascular diseases (CVDs) were diagnosed and forty were non-diagnosed (ND). Results: The mean age of individuals (n = 90) was 43.2 ± 14.4. The BMI and waist circumference of the CVDs group were statistically significantly higher than the ND group (p < 0.001). While the total caffeine consumption of the ND group was 209.34 ± 143.85?mg/day, consumption of the CVDs group was 209.99 ± 196.76?mg/day. LDL cholesterol and total cholesterol did not show statistically significant difference between the two groups. However, HDL cholesterol was significantly higher in the ND group (p ? 0.001). Conclusion: Present results show that daily caffeine consumption may partially affect blood parameters associated with cardiovascular diseases, especially in the presence of coronary artery disease. © The Author(s) 2022.
dc.identifier.doi10.1177/02601060221105030
dc.identifier.issn0260-1060
dc.identifier.pmid35763489
dc.identifier.scopus2-s2.0-85133388457
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1177/02601060221105030
dc.identifier.urihttps://hdl.handle.net/20.500.11776/11096
dc.identifier.wosWOS:000818505300001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTuğgüm, Sergen
dc.institutionauthorKağan, N.
dc.institutionauthorNizam, B.
dc.institutionauthorAlpsoy, Ş.
dc.language.isoen
dc.publisherSAGE Publications Ltd
dc.relation.ispartofNutrition and Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCaffeine
dc.subjectcardiovascular diseases
dc.subjectcoffee
dc.subjectcoffee consumption
dc.subjectfood consumption
dc.titleCaffeine intake in adults with cardiovascular diseases; A cross-sectional study
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Sağlık Yüksekokulu Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu